Literature DB >> 19888531

Factor VIII-eGFP fusion proteins with preserved functional activity for the analysis of the early secretory pathway of factor VIII.

Stefan Heinz1, Jörg Schüttrumpf, Jeremy C Simpson, Rainer Pepperkok, Gerry A Nicolaes, Daniela Abriss, Peter Milanov, Stefanie Roth, Erhard Seifried, Torsten Tonn.   

Abstract

Considering the difficulty in detecting factor (F)VIII in vivo, fluorescently labelled FVIII protein provides a tool to analyse the intracellular localisation, bio distribution, and pharmacokinetics of the protein in living organisms. Here, we report the use of FVIII full length and B-domain deleted proteins, fused to enhanced green fluorescent protein (eGFP) at the C-terminus of the coagulation protein via a nine amino acid spanning linker. Comparison of the FVIII-eGFP fusion proteins to their unlabelled counterparts showed no impairment with respect to recombinant expression levels, intracellular processing, specific coagulant activity and decay at physiological temperature. Confocal live cell imaging demonstrated ER-Golgi-transport of B-domain deleted FVIII-eGFP in vesicular tubular carriers. Using temperature blocks and release experiments, imaging of FVIII-eGFP fusion proteins enabled for the first time the visualisation of the early secretory pathway of B-domain deleted FVIII in living cells and in particular highlighted the apparent deficit of active transport carriers, an observation consistent with the low rates of FVIII secretion seen in recombinant expression systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19888531     DOI: 10.1160/TH08-12-0807

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  2 in total

1.  Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia A.

Authors:  Stefanie D Roth; Jörg Schüttrumpf; Peter Milanov; Daniela Abriss; Christopher Ungerer; Patricia Quade-Lyssy; Jeremy C Simpson; Rainer Pepperkok; Erhard Seifried; Torsten Tonn
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

2.  Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector delivery.

Authors:  Harrison C Brown; J Fraser Wright; Shangzhen Zhou; Allison M Lytle; Jordan E Shields; H Trent Spencer; Christopher B Doering
Journal:  Mol Ther Methods Clin Dev       Date:  2014-08-06       Impact factor: 6.698

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.